Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-27 15:57:57 - browse：71883

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： STAT Readout Newsletter: Biotech news today

leisure time

hotspot

WSS

Do masks work? RCTs can't tell us

In areas with more Black doctors, Black people live longer

The science behind Janet Jackson's pregnancy at 49

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Roivant's CEO is a star, but biotech's black hole persists

What would happen to your eyes if you looked at the solar eclipse?

hotspot

Wikipedia

knowledge

Cancer drug shortages should be causing more outrage

Roivant's CEO is a star, but biotech's black hole persists

Affirmative action in medical school literally saved lives

How AI can help patients find reliable information about doctors

How to save PrEP access — and even expand it

Do masks work? RCTs can't tell us

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Donald Trump's relentless attacks on special counsel Jack Smith

Drug repurposing or repositioning? The language matters

Donald Trump's relentless attacks on special counsel Jack Smith

focus

Results on Novartis prostate cancer therapy could expand its use

Roivant's CEO is a star, but biotech's black hole persists

Roivant's CEO is a star, but biotech's black hole persists

STAT Readout: Friday, Oct. 20 biotech updates

Is there really a nursing shortage in the U.S.?

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

explore

leisure time

hotspot

Wikipedia